Trial Profile
Double-blind, vehicle-controlled study to evaluate apoptosis in basal cell carcinoma treated with Aldara (Imiquimod) cream, 5% applied once or twice a day
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 May 2013
Price :
$35
*
At a glance
- Drugs Imiquimod (Primary)
- Indications Basal cell cancer
- Focus Therapeutic Use
- 25 Apr 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Apr 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Jul 2007 Status change